Search hospitals > Washington > Spokane
MultiCare Deaconess Cancer and Blood Specialty Center - Downtown
Claim this profileSpokane, Washington 99204
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Recurrence
Conducts research for Non-Small Cell Lung Cancer
85 reported clinical trials
2 medical researchers
Summary
MultiCare Deaconess Cancer and Blood Specialty Center - Downtown is a medical facility located in Spokane, Washington. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Recurrence, Non-Small Cell Lung Cancer and other specialties. MultiCare Deaconess Cancer and Blood Specialty Center - Downtown is involved with conducting 85 clinical trials across 256 conditions. There are 2 research doctors associated with this hospital, such as Alison K. Conlin and Jennifer Slim.Area of expertise
1Cancer
Global LeaderStage IV
Stage II
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Alison K. ConlinProvidence Portland Medical Center4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
103 reported clinical trials
179 drugs studied
Jennifer SlimMultiCare Tacoma General Hospital6 years of reported clinical research
Studies Cancer
Studies Breast Cancer
18 reported clinical trials
50 drugs studied
Clinical Trials running at MultiCare Deaconess Cancer and Blood Specialty Center - Downtown
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Bladder Cancer
Ovarian Tumors
Pancreatic Carcinoma
Testicular Carcinoma
Ovarian Carcinoma
Ovarian Choriocarcinoma
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at MultiCare Deaconess Cancer and Blood Specialty Center - Downtown?
MultiCare Deaconess Cancer and Blood Specialty Center - Downtown is a medical facility located in Spokane, Washington. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Recurrence, Non-Small Cell Lung Cancer and other specialties. MultiCare Deaconess Cancer and Blood Specialty Center - Downtown is involved with conducting 85 clinical trials across 256 conditions. There are 2 research doctors associated with this hospital, such as Alison K. Conlin and Jennifer Slim.